Nanis Nikolaos P. 4
4 · Teladoc Health, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Nanis Nikolaos P.
Chief Technology Officer
Transactions
- Sale
Common Stock
2024-07-02$9.39/sh−442$4,150→ 73,226 total - Exercise/Conversion
Restricted Stock Units
2024-07-01−1,233→ 6,165 total→ Common Stock (1,233 underlying) - Exercise/Conversion
Common Stock
2024-07-01+1,233→ 73,668 total
Footnotes (3)
- [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
- [F3]On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.